Positive correlation of galanin with glucose in healthy volunteers during an oral glucose tolerance test

Hormone and Metabolic Research

Volumn 39, Issue 1, 2007, Pages 53-55

  Legakis, I N ^a   Mantzouridis, T ^b   Mountokalakis, T ^b  

^a HENRY DUNANT HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

C peptide; Fasting state; Homeostasis; Insulin; Tolerance

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C PEPTIDE; CORTICOSTEROID DERIVATIVE; GALANIN; GLUCOSE; INSULIN; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; BLOOD; GLUCOSE TOLERANCE TEST; HEALTH;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; FEMALE; GALANIN; GLUCOSE TOLERANCE TEST; HEALTH; HUMANS; INSULIN; MALE;

EID: 33947579167     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-957346     Document Type: Article

References (28)

1. Vrontakis ME: Galanin, a biologically active peptide. Curr Drug Targets CNS Neurol Disord 2002; 1: 531-541
2. Greenberg GR, McDonald TJ: Effect of galanin and vagal integrity on insulin release in dogs. Pancreas 1988; 3: 122-127
3. Holst JJ, Bersani M, Hvidberg A, Knigge U, Christiansen E, Madsbad S, Harling H, Kofod H: On the effects of human galanin in man. Diabetologia 1993; 36: 653-657
4. McDonald TJ, Tu E, Brenner S, Zabel P, Behme M, Panchal C, Hramiak I, Barnett WB, Miller D, Dupre J: Canine, human, and rat plasma insulin responses to galanin administration: species response differences. Am J Physiol 1994; 266: E612-E617
5. Taborsky GJ Jr, Dunning BE, Havel PJ, Ahren B, Kowalyk S, Boyle MR, Verchere CB, Baskin DG, Mundinger TO: The canine sympathetic neuropeptide galanin: a neurotransmitter in pancreas, a neuromodulator in liver. Horm Metab Res 1999; 31: 351-354
6. Bauer FE, Zintel A, Kenny MJ, Calder D, Ghatei MA, Bloom SR: Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology 1989; 97: 260-264
7. Wilding JP: Neuropeptides and appetite control. Diabet Med 2002; 19: 619-627
8. Meczekalski B, Slopien R, Warenik-Szymankiewicz A: The concentration of galanin in postmenopausal women before and after application of hormone replacement therapy compared to women of reproductive age. Med Sci Monit 2001; 7: 928-932
9. Milewicz A, Mikulski E, Bidzinska B: Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus. Int J Obes Relat Metab Disord 2000; 24 (Suppl 2): S152-S153
10. Legakis I, Matzouridis T, Moutokalakis T: Positive correlation of galanin with glucose in type 2 diabetes. Diabetes Care 2005; 23: 759-760
11. Legakis IN: The role of galanin in metabolic disorders leading to type 2 diabetes mellitus. Drug News Perspect 2005; 18: 173-177
12. The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 (Supp 1): S5-S20
13. Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22
14. Shapiro SS, Wilk MB: An analysis of variance test for normality. Biometrika 1965; 52: 591-611
15. Adeghate E, Ponery AS: Large reduction in the number of galanin-immunoreactive cells in pancreatic islets of diabetic rats. J Neuroendocrinol 2001; 13: 706-710
16. Manabe T, Okada Y, Sawai H, Funahashi H, Yamamoto M, Hayakawa T, Yoshimura T: Effect of galanin on plasma glucose, insulin and pancreatic glucagon in dogs. J Int Med Res 2003; 31: 126-132
17. 2 and its new analogues on glucose-induced insulin secretion. Pol J Pharmacol 2002; 54: 133-141
18. Milewicz A, Mikulski E, Bidzinska B: Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus. Int J Obes Relat Metab Disord 2002; 24 (Suppl 2): S152-S153
19. Gilbey SG, Stephenson J, O'Halloran DJ, Burrin JM, Bloom SR: High-dose porcine galanin infusion and effect on intravenous glucose tolerance in humans. Diabetes 1989; 38: 1114-1116
20. Tang C, Akabayashi A, Manitiu A, Leibowitz SF: Hypothalamic galanin gene expression and peptide levels in relation to circulating insulin: possible role in energy balance. Neuroendocrinology 1997; 65: 265-275
21. Wang J, Leibowitz KL: Central insulin inhibits hypothalamic galanin and neuropeptide Y gene expression and peptide release in intact rats. Brain Res 1997; 777: 231-236
22. Milewicz A, Bidzinska B, Mikulski E, Demissie M, Tworowska U: Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels. Gynecol Endocrinol 2000; 14: 196-203
23. Baranowska B, Wasilewska-Dziubinska E, Radzikowska M, Plonowski A, Roguski K: Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa. Metabolism 1997; 46: 1384-1389
24. Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Roguski K, Polonowski A: Relationship among leptin, neuropeptide Y, and galanin in young women and in postmenopausal women. Menopause 2000; 7: 149-155
25. Celi F, Bini V, Papi F, Ferreti A, Mencacci M, Berioli MG, Giorgi De G, Falorni A: Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development. Clin Endocrin 2005; 63: 139-145
26. Ferrannini E, Cobelli C: The kinetics of insulin in man II. Role of the liver. Diabetes Metab Rev 1987; 3: 365-397
27. Polonsky KS, Frank B, Pugh W, Addis A, Karrsion T, Meier P, Tager H, Rubenstein A: The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes 1986; 35: 379-386
28. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992; 41: 368-377